The use of Sirolimus for an unresectable and refractory venous malformation: A case series

The use of Sirolimus for an unresectable and refractory venous malformation: A case series

Vascular malformations (VM) may become symptomatic and extensive, leading to deranged coagulation and bleeding. Sirolimus®, an antiangiogenic agent, has recently emerged as treatment for VM. We report its short-term outcomes for VMs of the extremities. Case 1: A 47-year-old female reported left fore...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniela Kristina Carolino, MD, Keiichi Muramatsu, MD, Yasuhiro Tani, MD, Hideaki Sugimoto, MD, Masaya Ueda, MD
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Radiology Case Reports
Subjects:
Rapamycin
Sirolimus
Venous malformation
Unresectable
Extremity
Online Access:http://www.sciencedirect.com/science/article/pii/S1930043325002262
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items